Trial intelligence / Profile preview

rhNGF Eye Drops in Dry Eye

NCT02101281Phase 2Completed

Sponsor
Dompé
Start
Jan 2014
Primary completion
Jan 2015
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of cenegermin in dry eye syndrome (DED), sponsored by Dompé. Started Jan 2014; status: completed.

02

Drugs

cenegermin
03

Conditions

dry eye syndrome (DED)

Beyond the preview

Go deeper on NCT02101281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02101281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call